190 related articles for article (PubMed ID: 25815200)
1. Patient access schemes in Asia-pacific markets: current experience and future potential.
Lu CY; Lupton C; Rakowsky S; Babar ZU; Ross-Degnan D; Wagner AK
J Pharm Policy Pract; 2015; 8(1):6. PubMed ID: 25815200
[TBL] [Abstract][Full Text] [Related]
2. [Risk sharing methods in middle income countries].
Inotai A; Kaló Z
Acta Pharm Hung; 2012; 82(1):43-52. PubMed ID: 22570986
[TBL] [Abstract][Full Text] [Related]
3. Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers.
Carlson JJ; Sullivan SD; Garrison LP; Neumann PJ; Veenstra DL
Health Policy; 2010 Aug; 96(3):179-90. PubMed ID: 20226559
[TBL] [Abstract][Full Text] [Related]
4. Improving Access to High-Cost Technologies in the Asia Region.
Mundy L; Trowman R; Kearney B
Int J Technol Assess Health Care; 2019 Jan; 35(3):168-175. PubMed ID: 31122302
[TBL] [Abstract][Full Text] [Related]
5. Innovative pharmaceutical pricing agreements in five European markets: A survey of stakeholder attitudes and experience.
Dunlop WCN; Staufer A; Levy P; Edwards GJ
Health Policy; 2018 May; 122(5):528-532. PubMed ID: 29567205
[TBL] [Abstract][Full Text] [Related]
6. Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies.
Kaplan WA; Ashigbie PG; Brooks MI; Wirtz VJ
J Pharm Policy Pract; 2017; 10():17. PubMed ID: 28523128
[TBL] [Abstract][Full Text] [Related]
7. How can we improve patients' access to new drugs under uncertainties? : South Korea's experience with risk sharing arrangements.
Lee B; Bae EY; Bae S; Choi HJ; Son KB; Lee YS; Jang S; Lee TJ
BMC Health Serv Res; 2021 Sep; 21(1):967. PubMed ID: 34521408
[TBL] [Abstract][Full Text] [Related]
8. Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force.
Garrison LP; Towse A; Briggs A; de Pouvourville G; Grueger J; Mohr PE; Severens JL; Siviero P; Sleeper M
Value Health; 2013; 16(5):703-19. PubMed ID: 23947963
[TBL] [Abstract][Full Text] [Related]
9. Patient access to medicines in two countries with similar health systems and differing medicines policies: Implications from a comprehensive literature review.
Babar ZU; Gammie T; Seyfoddin A; Hasan SS; Curley LE
Res Social Adm Pharm; 2019 Mar; 15(3):231-243. PubMed ID: 29678413
[TBL] [Abstract][Full Text] [Related]
10. Managed Entry Agreements: Policy Analysis From the European Perspective.
Dabbous M; Chachoua L; Caban A; Toumi M
Value Health; 2020 Apr; 23(4):425-433. PubMed ID: 32327159
[TBL] [Abstract][Full Text] [Related]
11. Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.
Adamski J; Godman B; Ofierska-Sujkowska G; Osińska B; Herholz H; Wendykowska K; Laius O; Jan S; Sermet C; Zara C; Kalaba M; Gustafsson R; Garuolienè K; Haycox A; Garattini S; Gustafsson LL
BMC Health Serv Res; 2010 Jun; 10():153. PubMed ID: 20529296
[TBL] [Abstract][Full Text] [Related]
12. Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers.
Carlson JJ; Gries KS; Yeung K; Sullivan SD; Garrison LP
Appl Health Econ Health Policy; 2014 Jun; 12(3):231-8. PubMed ID: 24664994
[TBL] [Abstract][Full Text] [Related]
13. Implementing Outcomes-Based Managed Entry Agreements for Rare Disease Treatments: Nusinersen and Tisagenlecleucel.
Facey KM; Espin J; Kent E; Link A; Nicod E; O'Leary A; Xoxi E; van de Vijver I; Zaremba A; Benisheva T; Vagoras A; Upadhyaya S
Pharmacoeconomics; 2021 Sep; 39(9):1021-1044. PubMed ID: 34231135
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea.
Hasan SS; Kow CS; Dawoud D; Mohamed O; Baines D; Babar ZU
Value Health Reg Issues; 2019 May; 18():18-23. PubMed ID: 30414506
[TBL] [Abstract][Full Text] [Related]
15. Government pharmaceutical pricing strategies in the Asia-Pacific region: an overview.
Verghese NR; Barrenetxea J; Bhargava Y; Agrawal S; Finkelstein EA
J Mark Access Health Policy; 2019; 7(1):1601060. PubMed ID: 31007877
[No Abstract] [Full Text] [Related]
16. Can't get no satisfaction? Will pay for performance help?: toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical products.
Towse A; Garrison LP
Pharmacoeconomics; 2010; 28(2):93-102. PubMed ID: 20085386
[TBL] [Abstract][Full Text] [Related]
17. Integrative Review of Managed Entry Agreements: Chances and Limitations.
Zampirolli Dias C; Godman B; Gargano LP; Azevedo PS; Garcia MM; Souza Cazarim M; Pantuzza LLN; Ribeiro-Junior NG; Pereira AL; Borin MC; de Figueiredo Zuppo I; Iunes R; Pippo T; Hauegen RC; Vassalo C; Laba TL; Simoens S; Márquez S; Gomez C; Voncina L; Selke GW; Garattini L; Kwon HY; Gulbinovic J; Lipinska A; Pomorski M; McClure L; Fürst J; Gambogi R; Ortiz CH; Canuto Santos VC; Araújo DV; Araujo VE; Acurcio FA; Alvares-Teodoro J; Guerra-Junior AA
Pharmacoeconomics; 2020 Nov; 38(11):1165-1185. PubMed ID: 32734573
[TBL] [Abstract][Full Text] [Related]
18. An assessment of innovative pricing schemes for the communication of value: is price discrimination and two-part pricing a way forward?
Hertzman P; Miller P; Tolley K
Expert Rev Pharmacoecon Outcomes Res; 2018 Feb; 18(1):5-12. PubMed ID: 29186996
[TBL] [Abstract][Full Text] [Related]
19. Accelerating patient access to oncology medicines with multiple indications in Europe.
Lawlor R; Wilsdon T; Darquennes E; Hemelsoet D; Huismans J; Normand R; Roediger A
J Mark Access Health Policy; 2021; 9(1):1964791. PubMed ID: 34436506
[No Abstract] [Full Text] [Related]
20. From Regulatory Approval to Subsidized Patient Access in the Asia-Pacific Region: A Comparison of Systems Across Australia, China, Japan, Korea, New Zealand, Taiwan, and Thailand.
Cook G; Kim H
Value Health Reg Issues; 2015 May; 6():40-45. PubMed ID: 29698191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
